Merck KGaA acquires QLight Nanotech stake
QLight Nanotech is developing quantum dot semiconductor nanoparticles for energy-efficient light sources and displays.
QLight Nanotech and Merck have been conducting joint research into this new class of materials for the past three years. Merck could further increase its stake in Qlight Nanotech, depending on reaching R&D milestones, as well as develop and commercialize the new products.
Based in Jerusalem, QLight Nanotech is a spin-off of Yissum Technology Transfer Company of the Hebrew University of Jerusalem.
QLight Nanotech scientific founder Prof. Uri Banin of Hebrew University, said "I am excited that our basic science discoveries on semiconductor nanocrystals are now being realized in innovative technological applications. The partnership with Merck, a world leader in materials for display applications, is a synergistic one allowing us at Qlight Nanotech to implement advanced chemicals manufacturing and applications’ know-how."
Qlight Nanotech CEO Kobi Olin said, “This is a major development for Qlight Nanotech to position us on the runway for becoming a leader in the emerging semiconductor nanoparticle materials and applications field. The Merck partnership is a strategic connection that will enable QLight Nanotech to achieve accelerated technology development and growth in collaboration with major international customers."
Published by Globes [online], Israel business news - www.globes-online.com - on May 22, 2012
© Copyright of Globes Publisher Itonut (1983) Ltd. 2012
- Tel Aviv market report
- Tel Aviv Stock Exchange
- Israeli stocks in NY
- Arbitrage gaps for dual-listed stocks
- Israeli stocks in Europe
- Israeli stocks on other markets
- Tel Aviv 25 options
- Mutual funds
- Current representative shekel rates
- Historical representative shekel rates
- Bank shekel rates
- Shekel/dollar options